Understanding changes in the right side of the heart in pulmonary hypertension
Official title: Right ventricle remodeling in pulmonary hypertension
Funded at Ohio State University · NIH-11247817 · Data updated 2026-11-12
This study is looking at how the right side of the heart changes in people with pulmonary hypertension, so we can better understand the condition and find new treatments to help those with heart problems.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project start | January 1, 2024 |
| Project end | December 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $48,386 |
| NIH project number | 3R01HL167963-02S1 |
| Project ID | NIH-11247817 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients diagnosed with pulmonary hypertension, particularly those experiencing right ventricle dysfunction.
✕Less likely to help
Patients with left ventricle dysfunction or those not diagnosed with pulmonary hypertension may not benefit from this research.
What this research studies
This research investigates how the right ventricle (RV) of the heart changes in patients with pulmonary hypertension (PH), a condition that can lead to serious heart problems. The study aims to uncover the unique biological processes of the RV compared to the left ventricle (LV), which may respond differently to treatments. By analyzing heart tissue from animal models, researchers will identify specific genes and immune responses that contribute to RV dysfunction. The ultimate goal is to develop targeted therapies that can improve outcomes for patients suffering from RV failure.
Why it matters
Potential benefit: If successful, this research could lead to new, effective treatments for patients with right ventricle dysfunction due to pulmonary hypertension.
How similar studies have gone: While there has been some research on left ventricle dysfunction, this focus on right ventricle biology in the context of pulmonary hypertension is relatively novel.
Where this research is happening
-
Ohio State University
Columbus, United States Active
Researchers
- Principal investigator: Gorr, Matthew William — Ohio State University
- Study coordinator: Gorr, Matthew William
Related research
Other NIH-funded projects on the same topics.
-
Understanding how CD4 T cells fuel schistosomiasis-related lung disease
A study explores how specific immune cells and inflammatory signals in schistosomiasis may contribute to pulmonary hypertension in people affected by the disease.
-
CD4 T Cells, Schistosoma, and Pulmonary Hypertension: Understanding How Immune Cells Drive Disease
A human-health focused study uses a mouse model and human samples to explore how immune cells and inflammation may contribute to a lung blood vessel disease linked to schistosomiasis.
-
CD4 T Cells and Schistosoma-Related Pulmonary Hypertension
A study to understand how specific immune cells behave in a lung complication caused by schistosomiasis, with the goal of finding targets to prevent or treat it.
-
Clinical CT Imaging to identify and subtype pulmonary hypertension in COPD
A new CT imaging approach aims to help doctors detect and classify pulmonary hypertension in people with COPD.
-
Right heart remodeling in pulmonary hypertension
In people with pulmonary hypertension, researchers are studying how the right side of the heart changes and why it fails, with the goal of finding new treatments.
-
TEMPO-PH: How the right heart adapts in pulmonary hypertension over time
A study to build a detailed molecular portrait of why the right side of the heart fails in pulmonary hypertension and how a common heart medicine might help.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.